SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Malaspina Andrea)
 

Sökning: WFRF:(Malaspina Andrea) > Neurofilaments in p...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00003501naa a2200433 4500
001oai:DiVA.org:umu-163682
003SwePub
008191021s2019 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1636822 URI
024a https://doi.org/10.1080/21678421.2019.16467692 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Benatar, Michael4 aut
2451 0a Neurofilaments in pre-symptomatic ALS and the impact of genotype
264 c 2019-08-21
264 1b Taylor & Francis,c 2019
338 a print2 rdacarrier
520 a Objective. To evaluate serum and cerebrospinal fluid (CSF) levels of phosphorylated neurofilament heavy (pNfH), and to compare these to levels of neurofilament light (NfL), as biomarkers of pre-symptomatic ALS. Design. The study population includes 34 controls, 79 individuals at-risk for ALS, 22 ALS patients, and 14 phenoconverters. At-risk individuals are enrolled through Pre-Symptomatic Familial ALS (Pre-fALS), a longitudinal natural history and biomarker study of individuals who are carriers of any ALS-associated gene mutation, but who demonstrate no clinical evidence of disease at the time of enrollment. pNfH and NfL in serum and CSF were quantified using established enzyme-linked immunosorbent assays. Results. There is a longitudinal increase in serum pNfH in advance of the emergence of clinically manifest ALS. A similar pattern is observed for NfL, but with the absolute levels also frequently exceeding a normative threshold. Although CSF data are more sparse, similar patterns are observed for both neurofilaments, with absolute levels exceeding a normative threshold prior to phenoconversion. In serum, these changes are observed in the 6-12 months prior to disease among SOD1 A4V mutation carriers, and as far back as 2 and 3.5 years, respectively, in individuals with a FUS c.521del6 mutation and a C9ORF72 hexanucleotide repeat expansion. Conclusions. Serum and CSF pNfH increase prior to phenoconversion. In CSF, the temporal course of these changes is similar to NfL. In serum, however, pNfH is less sensitive to pre-symptomatic disease than NfL. The duration of pre-symptomatic disease, as defined by changes in neurofilaments, may vary depending on underlying genotype.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reumatologi och inflammation0 (SwePub)302102 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Rheumatology and Autoimmunity0 (SwePub)302102 hsv//eng
653 a Amyotrophic lateral sclerosis
653 a neurofilaments
653 a biomarkers
653 a pre-symptomatic
653 a disease prevention
700a Wuu, Joanne4 aut
700a Lombardi, Vittoria4 aut
700a Jeromin, Andreas4 aut
700a Bowser, Robert4 aut
700a Andersen, Peter M.,d 1962-u Umeå universitet,Klinisk neurovetenskap4 aut0 (Swepub:umu)pean0001
700a Malaspina, Andrea4 aut
710a Umeå universitetb Klinisk neurovetenskap4 org
773t Amyotrophic Lateral Sclerosis and Frontotemporal Degenerationd : Taylor & Francisg 20:7-8, s. 538-548q 20:7-8<538-548x 2167-8421x 2167-9223
856u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768722
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-163682
8564 8u https://doi.org/10.1080/21678421.2019.1646769

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy